Valley National Advisers’s St Jude Medical STJ Stock Holding History

Valley National Advisers’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-33	Closed	-$3K	–	710
2016 Q4	$3K	Hold	33	–	–	﹤0.01%	552
2016 Q3	$3K	Sell	33 -21	-39%	-$1.7K	﹤0.01%	520
2016 Q2	$4K	Hold	54	–	–	﹤0.01%	485
2016 Q1	$3K	Hold	54	–	–	﹤0.01%	519
2015 Q4	$3K	Hold	54	–	–	﹤0.01%	518
2015 Q3	$3K	Hold	54	–	–	﹤0.01%	513
2015 Q2	$4K	Sell	54 -7	-11%	-$506	﹤0.01%	481
2015 Q1	$4K	Buy	+61	New	+$4.06K	﹤0.01%	464

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Valley National Advisers's STJ Position: Q1 2017 in Review

Valley National Advisers sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 33 shares — an estimated $3K sold.

Valley National Advisers first reported a position in STJ in Q1 2015 and held it in 8 quarters. The position peaked at $4K in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Valley National Advisers reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Valley National Advisers sold 33 St Jude Medical shares in Q1 2017, an estimated $3K.
Valley National Advisers first reported a position in St Jude Medical in Q1 2015 and held it in 8 quarters.
Valley National Advisers's St Jude Medical position peaked at $4K in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Valley National Advisers's 13F filing for Q1 2017, filed 12 May 2017.